369 results on '"Pals, Steven T."'
Search Results
2. MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas
3. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features
4. CXCR5+PD-1++ CD4+ T cells colonize infant intestines early in life and promote B cell maturation
5. Expanded ILC2s in human infant intestines promote tissue growth
6. A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways
7. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognoses and targetable genetic features
8. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype
9. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma
10. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins
11. Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
12. Illegitimate WNT Signaling Promotes Proliferation of Multiple Myeloma Cells
13. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins
14. The forkhead transcription factor FOXP1 represses human plasma cell differentiation
15. Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene
16. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival
17. Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation
18. FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells
19. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells
20. Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
21. Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma (Journal of Hematology & Oncology, (2021), 14, 1, (11), 10.1186/s13045-021-01031-3)
22. Memory CD4+CCR5+ T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1
23. Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival
24. Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations
25. A 43-YEAR-OLD FEMALE WITH MULTIFOCAL CEREBRAL LESIONS
26. miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes
27. A Human Homologue of the Rat Metastasis-Associated Variant of CD44 Is Expressed in Colorectal Carcinomas and Adenomatous Polyps
28. Additional file 1 of The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma
29. Syndecan-1 and stromal heparan sulfate proteoglycans: key moderators of plasma cell biology and myeloma pathogenesis
30. The small GTPase Ral mediates SDF-1–induced migration of B cells and multiple myeloma cells
31. AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma
32. Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
33. Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma
34. Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma
35. Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma
36. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation
37. Towards genomic-based prognostication and precision therapy for diffuse large B-cell lymphoma
38. Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial
39. High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype
40. MYD88 in the driver’s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications
41. Tissue-specific expression of IgG receptors by human macrophages ex vivo
42. MET Signaling Overcomes Epidermal Growth Factor Receptor Inhibition in Normal and Colorectal Cancer Stem Cells Causing Drug Resistance
43. Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial
44. Brutonʼs Tyrosine Kinase and Phospholipase Cγ2 Mediate Chemokine-Controlled B Cell Migration and Homing
45. Activation of Wnt signaling in the intestinal mucosa of Apc+/min mice does not cause overexpression of the receptor tyrosine kinase Met
46. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis
47. High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma
48. Immune responsiveness in renal transplant recipients: Mycophenolic acid severely depresses humoral immunity in vivo
49. Regulation of Cytokine Signaling by B Cell Antigen Receptor and CD40-controlled Expression of Heparan Sulfate Proteoglycans
50. Clinicopathological characteristics of T-NHL arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.